- AMTH has acquired China’s market-leader in urology and shock wave therapy devices
- Acquisition expands Advanced MedTech’s urological market access in China via a comprehensive nationwide sales & service network and an established local R&D, manufacturing & supply chain ecosystem
- Acquisition provides Advanced MedTech with an emerging markets medical device platform which aligns with China’s local medical device manufacturing strategy. It will serve domestic demand in China, the world’s second largest and fastest growing healthcare market, and supply to other global emerging markets.
Singapore and Shenzhen, China, 13 September 2022 – Integrated urology leader Advanced MedTech Holdings (AMTH or the Group) announced the acquisition of a majority interest in WIKKON, the Chinese market leader in urology and shock wave therapy devices. AMTH expects to acquire the remaining shares of WIKKON by the end of 2022. Based in the tech hub of Shenzhen, also known as China’s Silicon Valley, WIKKON specializes in the development and manufacturing of solutions to treat urological and orthopedic conditions such as kidney stones, erectile dysfunction and joint, muscle or tissue pain.
Established in 1996, WIKKON has the largest installed base of over 6,000 urology treatment devices in China and strong relationships with healthcare professionals. The acquisition will significantly strengthen AMTH’s direct presence in China.
Combining the German engineering strength of Dornier MedTech, AMTH’s wholly owned subsidiary, with the innovative capabilities of WIKKON, AMTH will be able to offer physicians access to an expanded product portfolio and build up a high potential platform for the development of a global value segment in urology.
With China’s focus on domestic sourcing for key medical devices and its sizeable domestic market, AMTH is well-positioned to serve the expanded needs of the world’s second largest and fastest growing healthcare market with deeper localization of R&D and manufacturing capabilities. WIKKON’s products are in use across more than 40 countries in Asia Pacific and the rest of the world, giving AMTH a strong platform to better serve the needs of global emerging markets from WIKKON’s base in Shenzhen.
Abel Ang, Group Chief Executive of Advanced MedTech, said: “We are now uniquely placed to aggressively grow in China’s sizeable market, which is best served by domestically produced devices. Advanced MedTech’s integrated urology platform is accelerated by WIKKON’s significant R&D, manufacturing, supply chain, and installed base of units. Our newly combined portfolio will allow us to serve urology customers seeking value oriented solutions right through to premium oriented customers globally.”
Chen Ming, Founder and Chairman of WIKKON, said: “We are excited to become part of the Advanced MedTech group. By combining our expertise on innovative technology, research and reach, we will be able to significantly expand our solutions to healthcare professionals all over the world.”
Ends
About Advanced MedTech Holdings
Advanced MedTech Holdings is a global medical technology leader with a core focus in urology devices and contract manufacturing services. The Group serves millions of patients and physicians in 100 countries worldwide. Advanced MedTech Holdings makes strategic investments in disruptive medical technology companies, strengthening its portfolio of healthcare solutions for customers around the world. Advanced MedTech Holdings is a wholly owned subsidiary of Temasek. For more information, visit https://www.advanced-medtech.com.
About Dornier MedTech
Dornier MedTech is a medical device company headquartered in Munich, Germany, and is a wholly owned subsidiary of Advanced MedTech. As pioneers of the shock wave lithotripsy method and a leader in urological care, Dornier is one of the most trusted names in the industry. Through its deep-rooted spirit of entrepreneurship and excellence, Dornier continues to spearhead innovation in urology, developing some of the highest quality urological devices on the market today. Given its vast array of clients, Dornier is leading technology and improving life across the globe. For more information, visit https://www.dornier.com.
About WIKKON
WIKKON (Shenzhen Wikkon Precision Instruments Co., Ltd.) is a High and New Technology Enterprise with medical device research, engineering and manufacturing capabilities, based in Shenzhen, China. Founded in 1996, WIKKON is dedicated to innovation in the field of Extracorporeal Shock Wave Lithotripsy (ESWL) for kidney stone removal, Extracorporeal Shock Wave Therapy (ESWT) for erectile dysfunction and joint pain relief and Urology Imaging Table for all-purpose of medical exams and procedures. For more information, visit https://eswl.com/